Literature DB >> 15955661

Ultrasound guided lithotripsy of salivary calculi using an electromagnetic lithotriptor.

G Eggers1, R Chilla.   

Abstract

Sialolithiasis is a common disease of the major salivary glands. A supplement to the traditional therapies is extracorporeal shock wave lithotripsy of the calculus. This method has been adopted from the therapy of renal or bladder calculi. Patients with a solitary calculus of parotid or submandibular gland were treated with a specially designed lithotriptor. In a retrospective study the results of this therapy were analysed. The success rate was far better for parotid gland calculi than for submandibular calculi. We could not find better results than those published in literature with other devices. In our therapeutic concept, sialolithotripsy is the therapy of first choice for single parotid gland calculi. For submandibular gland calculus this method is advisable in selected cases only.

Entities:  

Mesh:

Year:  2005        PMID: 15955661     DOI: 10.1016/j.ijom.2005.04.012

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  4 in total

1.  Sialolith removal in the submandibular region using surgical diode laser: report of two cases and literature review.

Authors:  Orion Luiz Haas; Neimar Scolari; Lucas da Silva Meirelles; André Xavier Favoretto; Rogério Belle de Oliveira
Journal:  Oral Maxillofac Surg       Date:  2018-01-22

Review 2.  Modern management of obstructive salivary diseases.

Authors:  P Capaccio; S Torretta; F Ottavian; G Sambataro; L Pignataro
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

3.  Prospective utility of therapeutic ultrasound in dentistry-Review with recent comprehensive update.

Authors:  Shalu Rai; Mandeep Kaur; Sumit Goel; Sapna Panjwani; Shailly Singh
Journal:  Adv Biomed Res       Date:  2012-08-28

Review 4.  Salivary lithotripsy in the era of sialendoscopy.

Authors:  P Capaccio; S Torretta; L Pignataro; M Koch
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.